Temporomandibular Joint Osteoarthritis: Regenerative Treatment by a Stem Cell Containing Advanced Therapy Medicinal Product (ATMP)—An In Vivo Animal Trial

Temporomandibular Joint Osteoarthritis: Regenerative Treatment by a Stem Cell Containing Advanced Therapy Medicinal Product (ATMP)—An In Vivo Animal Trial

Temporomandibular joint osteoarthritis (TMJ-OA) is a chronic degenerative disease that is often characterized by progressive impairment of the temporomandibular functional unit. The aim of this randomized controlled animal trial was a comparative analysis regarding the chondroregenerative potency of...

Full description

Bibliographic Details
Main Authors: Robert Köhnke, Marcus Oliver Ahlers, Moritz Alexander Birkelbach, Florian Ewald, Michael Krueger, Imke Fiedler, Björn Busse, Max Heiland, Tobias Vollkommer, Martin Gosau, Ralf Smeets, Rico Rutkowski
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:International Journal of Molecular Sciences
Subjects:
osteoarthritis
temporomandibular joint
regenerative therapy
stem cell therapy
regenerative medicine
TMJD
Online Access:https://www.mdpi.com/1422-0067/22/1/443

Internet

https://www.mdpi.com/1422-0067/22/1/443

Similar Items